Performance & Safety of the Lipo-transfer Cannulas in Patients Underlying

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05419037` - Natural History of Pregnancy and Pregnancy Outcomes in Metreleptin-Treated vs Untreated Subjects With Lipodystrophy
Recruiting	`NCT03059121` - The Cleveland Cardiometabolic Cohort
Completed	`NCT00656175` - Raltegravir Therapy for Women With HIV and Fat Accumulation	Phase 2
Completed	`NCT00202241` - The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDS	N/A
Completed	`NCT00006185` - Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy Syndrome	Phase 1
Recruiting	`NCT02262832` - Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy	Phase 3
Completed	`NCT01679197` - Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy	Phase 2
Completed	`NCT02647853` - Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers	Phase 1
Active, not recruiting	`NCT00715546` - Autologous Adipose-Derived Stem Cell Transplantation in Patients With Lipodystrophy	Phase 1
Completed	`NCT00069004` - A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth	N/A
Completed	`NCT00025883` - Leptin to Treat Lipodystrophy	Phase 2
Completed	`NCT00001142` - Metabolism and Body Shape of Healthy Children and Children With Chronic Infections	N/A
Active, not recruiting	`NCT02262806` - Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy	Phase 2
Completed	`NCT02258685` - Factors Mediating Gut Microbiota Dysbiosis and Metabolic Disease in HIV Patients.
Completed	`NCT00192621` - Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects	Phase 4
Completed	`NCT00006190` - A Study to Determine How and Why HIV-Infected Subjects on Anti-viral Treatment Develop Lipodystrophy	Phase 4
Recruiting	`NCT05930106` - Carotid Doppler Peak Velocity Variation in Liposuction Fluid Management	N/A
Completed	`NCT00004329` - Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy	N/A
Recruiting	`NCT04656054` - Hemoglobin Level, Coagulopathy Profile and Electrolyte Balance
Completed	`NCT00082628` - Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients	Phase 3

NCT number	NCT06089759
Study type	Observational
Source	Aesthetic Group
Contact	Valérie BOQUET
Phone	+33(3).44.74.19.95
Email	v.boquet@aestheticgroup.fr
Status	Recruiting
Phase
Start date	August 30, 2023
Completion date	April 4, 2024

Performance and Safety of the Lipo-transfer Cannulas in Patients Underlying Lipofilling Treatment

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms